BMC Endocrine Disorders (May 2023)

Serum homocysteine concentration as a marker for advanced diabetic nephropathy in a cohort of elderly patients

  • Xulei Zheng,
  • Qiaorui Liu,
  • Zhiwen Liu

DOI
https://doi.org/10.1186/s12902-023-01342-1
Journal volume & issue
Vol. 23, no. 1
pp. 1 – 7

Abstract

Read online

Abstract Background Hyperhomocysteinemia has been linked with chronic kidney disease (CKD). The present study investigated whether homocysteine (Hcy) serum levels might serve as a marker for the advancement of diabetic nephropathy (DN). Methods Clinical and laboratory indicators including Hcy, vitamin D (VD), urine protein, estimated glomerular filtration rate (eGFR) and the urinary protein/creatinine ratio in subjects > 65 years with DN (n = 1,845), prediabetes (n = 1,180) and in a non-diabetes (control) group (n = 28,720) were analyzed. Results DN patients had elevated Hcy concentrations, decreased VD and higher urinary protein levels, a reduced eGFR and a higher urinary protein/creatinine ratio compared with prediabetic and control subjects. After correcting for urinary protein quantitation, multivariate analysis revealed that both the Hcy concentration (P 12 µmol/L was a cut-off value for predicting advanced DN. Conclusion Hcy serum concentration is a potential marker for the advancement of CKD in DN but not prediabetes patients.

Keywords